Pfizer Picks Boshoff To Head R&D, A Smooth Transition In An Uncertain Time

Chris Boshoff has been with Pfizer more than 10 years and has led oncology R&D and the integration of Seagen. He will succeed Mikael Dolsten, who will depart after leading R&D for nearly 15 years.